Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.
about
Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccineDiscerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacyEIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophagesEquine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from diseaseEnvelope determinants of equine lentiviral vaccine protection.Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency.A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses.Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines.CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteinsEarly detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horsesEnvelope variation as a primary determinant of lentiviral vaccine efficacy.Cytotoxic T lymphocytes in protection against equine infectious anemia virus.Development of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus.Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virusInfluence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.Development, evaluation, and laboratory validation of immunoassays for the diagnosis of equine infectious anemia (EIA) using recombinant protein produced from a synthetic p26 gene of EIA virus.Sero-surveillance of equine infectious anemia virus in equines in India during more than a decade (1999-2012).An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity.Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.Molecular characterization of equine infectious anaemia virus from a major outbreak in southeastern France.Distribution of equine infectious anemia in horses in the north of Minas Gerais State, Brazil.Subpopulations of equine infectious anemia virus Rev coexist in vivo and differ in phenotype.Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses.Epitope shifting of gp90-specific cellular immune responses in EIAV-infected ponies.Epidemiology and genetic characterization of equine infectious anaemia virus strains isolated in Belgium in 2010.Differential mortalities of dengue-infectedAedes aegypti: preliminary results
P2860
Q21131325-136AC98C-4AED-4E60-B5ED-DDA37BA5BEC3Q24556682-CC0502FD-AFE0-43DD-9D43-BA380F2BC92EQ33620921-47A503E1-5D84-43CE-AC21-A1E2890DF865Q33840365-03AE8727-EFC9-4E66-957F-C6C27D80C5F5Q34349343-D76313B5-BF48-4923-A24F-D5BE7805F250Q34380211-EDB731A0-461C-44DE-8F77-9B5BB59B1FBCQ34778836-0E54A3B7-061C-4095-BC53-CCF259D047E7Q35077483-FB891F8E-7740-48BA-AC15-1527FF30F7A7Q35148952-83FC0897-E125-4CCE-BCFD-0CC4EBE9BCB4Q35758001-3DEC120E-E784-461A-AAC4-7D61A4B03D68Q35928180-03C49A32-25E9-4FEF-A01C-015F62CB1E16Q35929492-FD87EC19-9BC8-477D-8B58-8A2131027273Q35948180-ADCA64D0-0846-401B-8C25-0015BEBE2C3DQ36002639-12FBA274-D7E5-4F0F-BA0E-AB88FBBFCC3CQ36177395-CFDA73AB-9E8B-4508-93BB-EDC9DFFD29BFQ36328526-B4257150-2918-4C07-A7BA-722B59DD523EQ36746968-5FFF769F-1871-4403-928F-15ACA94A5569Q36953913-0EBB8ED7-8842-4D23-ADE3-02D6733F292DQ37321505-4F0A045E-5699-4F2F-8E55-0B5016E7A1AFQ37321535-03A17984-9F8A-4CC1-A7A5-F96736546395Q37405780-D6F88256-FAA5-4860-A087-AF43C58B9861Q37666746-85D20048-B470-48AF-AFB9-5469A3287138Q38735230-E7892DFA-5D53-4CE3-86D4-C67E0900A155Q38786499-139C5A33-4217-41A2-8612-18B273F2D8B3Q39771514-F318912D-C770-408E-BEFA-B6D5A8F64EF6Q40132894-8EFE4BBC-812F-4015-A7C2-6CDDAD66563EQ40267080-4152EBA8-6614-46A9-BDFD-23275E6BE7C2Q41759578-5107246E-A53D-44AB-A911-A92F73187357Q42285558-8D466F41-A722-4384-8535-89C104895555Q58134682-09915779-712F-44F7-9CC4-BA63D01CAFF7
P2860
Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Immune responses and viral rep ...... quine infectious anemia virus.
@en
Immune responses and viral rep ...... quine infectious anemia virus.
@nl
type
label
Immune responses and viral rep ...... quine infectious anemia virus.
@en
Immune responses and viral rep ...... quine infectious anemia virus.
@nl
prefLabel
Immune responses and viral rep ...... quine infectious anemia virus.
@en
Immune responses and viral rep ...... quine infectious anemia virus.
@nl
P2093
P2860
P1433
P1476
Immune responses and viral rep ...... quine infectious anemia virus.
@en
P2093
P2860
P304
P356
10.1128/JVI.74.13.5968-5981.2000
P407
P577
2000-07-01T00:00:00Z